453 related articles for article (PubMed ID: 15581975)
61. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
[TBL] [Abstract][Full Text] [Related]
63. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
64. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
65. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T
Gynecol Oncol; 2006 Oct; 103(1):155-9. PubMed ID: 16545437
[TBL] [Abstract][Full Text] [Related]
66. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
67. Endometrial stromal sarcoma: clinico-pathological report of four cases and review of the literature.
Berceanu S; Pătraşcu A; Berceanu C; Tica AA; Bădulescu A
Rom J Morphol Embryol; 2008; 49(2):251-5. PubMed ID: 18516335
[TBL] [Abstract][Full Text] [Related]
68. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
[TBL] [Abstract][Full Text] [Related]
69. A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.
Salvatierra A; Tarrats A; Gomez C; Sastre JM; Balaña C
Gynecol Oncol; 2006 Jun; 101(3):545-7. PubMed ID: 16487996
[TBL] [Abstract][Full Text] [Related]
70. Endometrial stromal sarcoma arising from endometriosis: a clinicopathological study and literature review.
Lan C; Huang X; Lin S; Cai M; Liu J
Gynecol Obstet Invest; 2012; 74(4):288-97. PubMed ID: 22986788
[TBL] [Abstract][Full Text] [Related]
71. Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence.
Koskas M; Morice P; Yazbeck C; Duvillard P; Walker F; Madelenat P
Anticancer Res; 2009 Oct; 29(10):4147-50. PubMed ID: 19846964
[TBL] [Abstract][Full Text] [Related]
72. Lymph node metastases in low-grade endometrial stromal sarcoma.
Riopel J; Plante M; Renaud MC; Roy M; Têtu B
Gynecol Oncol; 2005 Feb; 96(2):402-6. PubMed ID: 15661228
[TBL] [Abstract][Full Text] [Related]
73. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
74. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches.
Barakat RR; Lev G; Hummer AJ; Sonoda Y; Chi DS; Alektiar KM; Abu-Rustum NR
Gynecol Oncol; 2007 Apr; 105(1):150-6. PubMed ID: 17197012
[TBL] [Abstract][Full Text] [Related]
75. Endometrial adenocarcinoma: an analysis of treatment and outcome.
Byrd LM; Swindell R; Webber-Rookes D; Hannon R; Hunter RD; Livsey J; Davidson SE
Oncol Rep; 2008 Nov; 20(5):1221-8. PubMed ID: 18949425
[TBL] [Abstract][Full Text] [Related]
76. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
77. Transition of endometrial stromal sarcoma into high-grade sarcoma.
Amant F; Woestenborghs H; Vandenbroucke V; Berteloot P; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2006 Dec; 103(3):1137-40. PubMed ID: 16919712
[TBL] [Abstract][Full Text] [Related]
78. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
Eltabbakh GH; Shamonki J; Mount SL
Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
[TBL] [Abstract][Full Text] [Related]
79. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
Neubauer NL; Havrilesky LJ; Calingaert B; Bulusu A; Bernardini MQ; Fleming ND; Bland AE; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):511-6. PubMed ID: 19144394
[TBL] [Abstract][Full Text] [Related]
80. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
